Trial Profile
A Phase 1, Open-label, Randomized, PK and Safety Study To Assess Bronchopulmonary Disposition of Intravenous TP-6076 in Healthy Men and Women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Dec 2021
Price :
$35
*
At a glance
- Drugs TP 6076 (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Acronyms BAL
- Sponsors Tetraphase Pharmaceuticals
- 16 Dec 2021 Status changed from active, no longer recruiting to completed.
- 10 Sep 2019 Planned End Date changed from 1 May 2019 to 28 Feb 2020.
- 10 Sep 2019 Status changed from recruiting to active, no longer recruiting.